Risk factors for anemia in patients with chronic kidney disease A protocol for systematic review and meta-analysis

被引:3
作者
Yin, Ping [1 ]
Wu, Quan [2 ]
Shou, Lihong [1 ]
Dong, Xiaohui [1 ]
机构
[1] Huzhou Univ, Dept Hematol, Huzhou Cent Hosp, Affiliated Cent Hosp, 1558 Sanhuanbei Rd, Huzhou 313000, Zhejiang, Peoples R China
[2] Huzhou Univ, Clin Lab, Huzhou Cent Hosp, Affiliated Cent Hosp, 1558 Sanhuanbei Rd, Huzhou, Zhejiang, Peoples R China
关键词
adverse effects; anemia; chronic kidney disease; meta-analysis; ERYTHROPOIETIN; MANAGEMENT;
D O I
10.1097/MD.0000000000027371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Anemia in patients with chronic kidney disease (CKD) presents significant impacts on patients, the health-care system, and financial resources. Therefore, this study aimed to identify the risk factors of anemia among CKD patients. Methods: This meta-analysis was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols statement guidelines. Studies were identified through systematic searches in September 2021 with no restrictions on date and time, and publication status using the following bibliographic databases: Embase, Medline, PubMed, Web of Science, Science Direct, and the Cochrane Library. The search was conducted using the following terms and phrases: "anemia", "risk factors", "associated factors", "chronic kidney injury", "chronic kidney disease", and "chronic renal insufficiency". The quality of each included study was assessed according to the Newcastle-Ottawa scale. Meta-analysis was performed using TATA(TM) version 14 statistical software for Windows(TM). Results: The results of this systematic review and meta-analysis will be published in a peer-reviewed journal. Conclusion: This meta-analysis may help policymakers and program managers design evidence-based interventions on preventing the occurrence of anemia with CKD patient populations.
引用
收藏
页数:3
相关论文
共 17 条
  • [1] Mechanisms of Anemia in CKD
    Babitt, Jodie L.
    Lin, Herbert Y.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1631 - 1634
  • [2] Chronic Kidney Disease Diagnosis and Management: A Review
    Chen, Teresa K.
    Knicely, Daphne H.
    Grams, Morgan E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (13): : 1294 - 1304
  • [3] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [4] Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: An overview
    Dowling, Thomas C.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (13) : S3 - S7
  • [5] Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
    Hayashi, T
    Suzuki, A
    Shoji, T
    Togawa, M
    Okada, N
    Tsubakihara, Y
    Imai, E
    Hori, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) : 250 - 256
  • [6] Kim Gheun-Ho, 2019, Electrolyte Blood Press, V17, P1, DOI 10.5049/EBP.2019.17.1.1
  • [7] Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    Levey, AS
    Eckardt, KU
    Tsukamoto, Y
    Levin, A
    Coresh, J
    Rossert, J
    de Zeeuw, D
    Hostetter, TH
    Lameire, N
    Eknoyan, G
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (06) : 2089 - 2100
  • [8] The Current State of Peritoneal Dialysis
    Mehrotra, Rajnish
    Devuyst, Olivier
    Davies, Simon J.
    Johnson, David W.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (11): : 3238 - 3252
  • [9] Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.b2700, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.07.299]
  • [10] Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
    Noonan, Megan L.
    Clinkenbeard, Erica L.
    Ni, Pu
    Swallow, Elizabeth A.
    Tippen, Samantha P.
    Agoro, Rafiou
    Allen, Matthew R.
    White, Kenneth E.
    [J]. PHYSIOLOGICAL REPORTS, 2020, 8 (11):